Notably, the current investigations were restricted to downstream MRI measures of CSVD and do not provide insight about other diseases like Alzheimer’s disease, in which resistance and resilience conferred by the HVP are imaginable and could be assessed in relation to tau or Aβ load. The gene discussed is MAPT; the disease is Alzheimer disease.